Institutional Fund
Avoro Capital Advisors LLC
New York, NYCIK 16333136 filings on record
Portfolio Value
$10.15B
Q1 2026
Holdings
30
Reported positions
New Buys
4
Opened this quarter
QoQ Change
-0.2%
from $10.17B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- United Therapeutics Corp Del15.4%
- Ascendis Pharma A/S11.4%
- Madrigal Pharmaceuticals Inc9.4%
- Krystal Biotech Inc7.4%
- Argenx Se7.2%
- Arrowhead Pharmaceuticals In6.6%
- Other42.7%
Portfolio Holdings
30 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | United Therapeutics Corp Del | 2.63M | $1.56B | 15.4% | +23.9K | Added |
| 2 | Ascendis Pharma A/S | 5.06M | $1.16B | 11.4% | −48.6K | Reduced |
| 3 | Madrigal Pharmaceuticals Inc | 1.82M | $951.76M | 9.4% | +10.7K | Added |
| 4 | Krystal Biotech Inc | 2.89M | $746.26M | 7.4% | 0 | Held |
| 5 | Argenx Se | 1.00M | $730.25M | 7.2% | +10.0K | Added |
| 6 | Arrowhead Pharmaceuticals In | 10.70M | $670.89M | 6.6% | +75.0K | Added |
| 7 | Kymera Therapeutics Inc | 7.47M | $622.57M | 6.1% | 0 | Held |
| 8 | Apellis Pharmaceuticals Inc | 12.22M | $491.70M | 4.8% | 0 | Held |
| 9 | Centessa Pharmaceuticals PLC | 11.43M | $454.02M | 4.5% | −3.13M | Reduced |
| 10 | Celcuity Inc | 3.38M | $385.22M | 3.8% | +263.9K | Added |
20 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio